COVID-19 treatment

NBE July 22, 2020

Novartis launches first-of-its-kind not-for-profit portfolio of medicines for symptomatic treatment of COVID-19, the company said. The new initiative of Novartis aims to help patients in low-income and lower-middle-income countries (LIC; LMIC) access affordable medicines to treat the major symptoms of COVID-19 – a critical need in the absence of a vaccine or curative treatment.